Last Updated: July 25, 2024 at 8:11 p.m. ET
First Published: July 25, 2024 at 6:01 p.m. ET
DexCom Inc., a maker of monitoring devices for diabetes patients, cut its full-year sales outlook on Thursday — a move that surprised some analysts and investors and sent its stock tumbling after hours — as the company deals with a shortfall in new patients and weaker trends abroad.
Shares of DexCom DXCM fell 36.8% after hours on Thursday, after holding steady through much of the year.